Patents by Inventor Harold Scott

Harold Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11788369
    Abstract: A method and apparatus for recovering cores from downhole environments where down hole environmental parameters are measured during coring operations to maximize the success of core recovery.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: October 17, 2023
    Assignee: PROFESSIONAL CORING ENTERPRISES, LLC
    Inventors: Jamie Mark Alleman, Karen L. O'Neal, William Harold Scott, III
  • Patent number: 11767293
    Abstract: The various aspects present inventions provide various crystalline forms of (S)-(?)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same. In various aspects, the inventions also provide methods of resolving racemic amisulpride.
    Type: Grant
    Filed: May 19, 2022
    Date of Patent: September 26, 2023
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
  • Publication number: 20230285356
    Abstract: Provided are compositions comprising unequal mixtures of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof, where the amount of (R)-amisulpride is greater than the amount of (S)-amisulpride, compositions and medicaments comprising the same used for the treatment of various diseases and disorders, and methods of using same for the treatment of various diseases and disorders, including, but not limited to, dosage regimens. In addition, provided are various formulations thereof, including, but not limited to, formulations employing polymorphs of enantiomeric amisulpride.
    Type: Application
    Filed: October 31, 2022
    Publication date: September 14, 2023
    Inventors: Seth Cabot Hopkins, Kenneth Stephen Koblan, John R. Snoonian, Harold Scott Wilkinson
  • Publication number: 20230167701
    Abstract: A method and apparatus for recovering cores from downhole environments where downhole environmental parameters are measured during coring operations to maximize the success of core recovery.
    Type: Application
    Filed: January 12, 2023
    Publication date: June 1, 2023
    Inventors: Jamie Mark ALLEMAN, Karen L. O'Neal, William Harold Scott, III
  • Publication number: 20230072389
    Abstract: The various aspects present inventions provide various crystalline forms of (S)-(?)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same. In various aspects, the inventions also provide methods of resolving racemic amisulpride.
    Type: Application
    Filed: May 19, 2022
    Publication date: March 9, 2023
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
  • Publication number: 20220402937
    Abstract: Provided are salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various of crystal forms thereof, and compositions, medicaments, pharmaceutically acceptable formulations thereof, and methods of making same. In addition, provided are compounds comprising specific particle size distributions of crystalline (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine HCl and methods of making and modulating the particle size distributions.
    Type: Application
    Filed: July 22, 2022
    Publication date: December 22, 2022
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Andrea BAUER, Nandkumar Nivritti BHOGLE, Xiaoxia CHEN, Shahla JAMZAD, Robert Joseph PRYTKO, Kostas SARANTEAS, Michael Joseph SIZENSKY, Harold Scott WILKINSON, Haitao ZHANG
  • Patent number: 11517558
    Abstract: Provided are compositions comprising unequal mixtures of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof, where the amount of (R)-amisulpride is greater than the amount of (S)-amisulpride, compositions and medicaments comprising the same used for the treatment of various diseases and disorders, and methods of using same for the treatment of various diseases and disorders, including, but not limited to, dosage regimens. In addition, provided are various formulations thereof, including, but not limited to, formulations employing polymorphs of enantiomeric amisulpride.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: December 6, 2022
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Seth Cabot Hopkins, Kenneth Stephen Koblan, John R. Snoonian, Harold Scott Wilkinson
  • Publication number: 20220349271
    Abstract: A method and apparatus for recovering cores from downhole environments where down hole environmental parameters are measured during coring operations to maximize the success of core recovery.
    Type: Application
    Filed: June 30, 2022
    Publication date: November 3, 2022
    Inventors: Jaime Mark ALLEMAN, Karen L. O'Neal, William Harold Scott, III
  • Patent number: 11440921
    Abstract: Provided are salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various of crystal forms thereof, and compositions, medicaments, pharmaceutically acceptable formulations thereof, and methods of making same. In addition, provided are compounds comprising specific particle size distributions of crystalline (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine HCl and methods of making and modulating the particle size distributions.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: September 13, 2022
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Andrea Bauer, Nandkumar Nivritti Bhogle, Xiaoxia Chen, Shahla Jamzad, Robert Joseph Prytko, Kostas Saranteas, Michael Joseph Sizensky, Harold Scott Wilkinson, Haitao Zhang
  • Patent number: 11370753
    Abstract: The various aspects present inventions provide various crystalline forms of (S)-(?)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same. In various aspects, the inventions also provide methods of resolving racemic amisulpride.
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: June 28, 2022
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
  • Publication number: 20220098163
    Abstract: The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.
    Type: Application
    Filed: June 15, 2021
    Publication date: March 31, 2022
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Nandkumar Nivritti BHOGLE, Takahiko HASHIZUKA, Robert Joseph PRYTKO, John R. SNOONIAN, Harold Scott WILKINSON, Haitao ZHANG
  • Publication number: 20210315860
    Abstract: Provided are compositions comprising unequal mixtures of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof, where the amount of (R)-amisulpride is greater than the amount of (S)-amisulpride, compositions and medicaments comprising the same used for the treatment of various diseases and disorders, and methods of using same for the treatment of various diseases and disorders, including, but not limited to, dosage regimens. In addition, provided are various formulations thereof, including, but not limited to, formulations employing polymorphs of enantiomeric amisulpride.
    Type: Application
    Filed: November 13, 2020
    Publication date: October 14, 2021
    Inventors: Seth Cabot Hopkins, Kenneth Stephen Koblan, John R. Snoonian, Harold Scott Wilkinson
  • Patent number: 11136304
    Abstract: The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: October 5, 2021
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Nandkumar Nivritti Bhogle, Takahiko Hashizuka, Robert Joseph Prytko, John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
  • Publication number: 20210246747
    Abstract: A method and apparatus for recovering cores from downhole environments where down hole environmental parameters are measured during coring operations to maximize the success of core recovery.
    Type: Application
    Filed: February 3, 2021
    Publication date: August 12, 2021
    Inventors: Jamie Mark Alleman, Karen L. O'Neal, William Harold Scott, III
  • Patent number: 11066380
    Abstract: The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: July 20, 2021
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Nandkumar Nivritti Bhogle, Takahiko Hashizuka, Robert Joseph Prytko, John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
  • Publication number: 20210061759
    Abstract: The various aspects present inventions provide various crystalline forms of (S)-(?)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same. In various aspects, the inventions also provide methods of resolving racemic amisulpride.
    Type: Application
    Filed: August 17, 2020
    Publication date: March 4, 2021
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
  • Publication number: 20210053983
    Abstract: Provided are salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various of crystal forms thereof, and compositions, medicaments, pharmaceutically acceptable formulations thereof, and methods of making same. In addition, provided are compounds comprising specific particle size distributions of crystalline (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine HCl and methods of making and modulating the particle size distributions.
    Type: Application
    Filed: August 28, 2020
    Publication date: February 25, 2021
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Andrea BAUER, Nandkumar Nivritti BHOGLE, Xiaoxia CHEN, Shahla JAMZAD, Robert Joseph PRYTKO, Kostas SARANTEAS, Michael Joseph SIZENSKY, Harold Scott WILKINSON, Haitao ZHANG
  • Patent number: 10874639
    Abstract: Provided are compositions comprising unequal mixtures of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof, where the amount of (R)-amisulpride is greater than the amount of (S)-amisulpride, compositions and medicaments comprising the same used for the treatment of various diseases and disorders, and methods of using same for the treatment of various diseases and disorders, including, but not limited to, dosage regimens. In addition, provided are various formulations thereof, including, but not limited to, formulations employing polymorphs of enantiomeric amisulpride.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: December 29, 2020
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Seth Cabot Hopkins, Kenneth Stephen Koblan, John R. Snoonian, Harold Scott Wilkinson
  • Patent number: 10800738
    Abstract: The various aspects present inventions provide various crystalline forms of (S)-(?)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same. In various aspects, the inventions also provide methods of resolving racemic amisulpride.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: October 13, 2020
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
  • Publication number: 20200290987
    Abstract: The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.
    Type: Application
    Filed: March 13, 2020
    Publication date: September 17, 2020
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Nandkumar Nivritti BHOGLE, Takahiko HASHIZUKA, Robert Joseph PRYTKO, John R. SNOONIAN, Harold Scott WILKINSON, Haitao ZHANG